226 related articles for article (PubMed ID: 28126912)
1. Growth Hormone With Aromatase Inhibitor May Improve Height in CYP11B1 Congenital Adrenal Hyperplasia.
Hawton K; Walton-Betancourth S; Rumsby G; Raine J; Dattani M
Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28126912
[TBL] [Abstract][Full Text] [Related]
2. Restoration of Height after 11 Years of Letrozole Treatment in 11β-Hydroxylase Deficiency.
Atay Z; Turan S; Buğdaycı O; Guran T; Bereket A
Horm Res Paediatr; 2019; 92(3):203-208. PubMed ID: 31454824
[TBL] [Abstract][Full Text] [Related]
3. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
Mauras N; Gonzalez de Pijem L; Hsiang HY; Desrosiers P; Rapaport R; Schwartz ID; Klein KO; Singh RJ; Miyamoto A; Bishop K
J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
Quintos JB; Vogiatzi MG; Harbison MD; New MI
J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with GH and anastrozole in a pubertal boy with Cushing's disease and postsurgical GH deficiency.
Boronat M; Marrero D; López-Plasencia Y; Nóvoa Y; García-Delgado Y; Nóvoa FJ
Eur J Endocrinol; 2012 Jun; 166(6):1101-5. PubMed ID: 22447814
[TBL] [Abstract][Full Text] [Related]
6. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
[TBL] [Abstract][Full Text] [Related]
7. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
Halper A; Sanchez B; Hodges JS; Dengel DR; Petryk A; Sarafoglou K
Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802
[TBL] [Abstract][Full Text] [Related]
8. Letrozole as a booster therapy in growth hormone deficiency.
Kumar KV; Jayaraman M; Verma A; Modi KD
Indian Pediatr; 2009 Jul; 46(7):625-7. PubMed ID: 19638662
[TBL] [Abstract][Full Text] [Related]
9. Aromatase Inhibitor as Treatment for Severely Advanced Bone Age in Congenital Adrenal Hyperplasia: A Case Report.
Goedegebuure WJ; Hokken-Koelega ACS
Horm Res Paediatr; 2019; 92(3):209-213. PubMed ID: 31390647
[TBL] [Abstract][Full Text] [Related]
10. Update on treatment strategies for optimization of final adult height in children with congenital adrenal hyperplasia.
Javed A; Lteif A; Kumar S
Pediatr Endocrinol Rev; 2012 Nov; 10(1):164-73. PubMed ID: 23469393
[TBL] [Abstract][Full Text] [Related]
11. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
[TBL] [Abstract][Full Text] [Related]
12. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.
Bulsari K; Falhammar H
Endocrine; 2017 Jan; 55(1):19-36. PubMed ID: 27928728
[TBL] [Abstract][Full Text] [Related]
13. Combination growth hormone and gonadotropin releasing hormone analog therapy in 11beta-hydroxylase deficiency.
Bajpai A; Kabra M; Menon PS
J Pediatr Endocrinol Metab; 2006 Jun; 19(6):855-7. PubMed ID: 16886593
[TBL] [Abstract][Full Text] [Related]
14. Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up?
Faglia G; Arosio M; Porretti S
J Endocrinol Invest; 2000 Dec; 23(11):721-3. PubMed ID: 11194703
[TBL] [Abstract][Full Text] [Related]
15. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.
Papadimitriou DT; Dermitzaki E; Papagianni M; Papaioannou G; Papaevangelou V; Papadimitriou A
J Endocrinol Invest; 2016 Apr; 39(4):439-46. PubMed ID: 26507391
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
Hero M; Norjavaara E; Dunkel L
J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
[TBL] [Abstract][Full Text] [Related]
17. Height augmentation in 11β-hydroxylase deficiency congenital adrenal hyperplasia.
Nour MA; Pacaud D
Int J Pediatr Endocrinol; 2015; 2015(1):12. PubMed ID: 25983757
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia.
Liu SC; Suresh M; Jaber M; Mercado Munoz Y; Sarafoglou K
Front Endocrinol (Lausanne); 2023; 14():1101843. PubMed ID: 36936152
[TBL] [Abstract][Full Text] [Related]
19. Growth impairment in a boy with late-onset congenital adrenal hyperplasia and anorexia nervosa.
Niedziela M; Sippell W
Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):180-3. PubMed ID: 20198557
[TBL] [Abstract][Full Text] [Related]
20. Letrozole significantly improves growth potential in a pubertal boy with growth hormone deficiency.
Zhou P; Shah B; Prasad K; David R
Pediatrics; 2005 Feb; 115(2):e245-8. PubMed ID: 15653791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
